MediPharm Labs Corp. (TSX: LABS), a pharmaceutical company specializing in precision-based cannabinoids, has issued a voting recommendation for its upcoming Annual and Special Meeting of Shareholders on June 16, 2025. The company is urging shareholders to vote in favor of its nominees using the GREEN proxy or GREEN voting instruction form. This follows an amended dissident proxy circular filed by Regan McGee, controlling shareholder and CEO of Apollo Technology Capital Corporation, who is seeking to elect himself and five other directors to MediPharm's board. MediPharm has expressed concerns regarding McGee's qualifications and the lack of a clear strategy from Apollo, advising shareholders to disregard any outreach from the dissident group and to ensure their votes are counted by obtaining their 16-digit control number from their broker.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.